ArticleBMC cancer2018

Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: a case report.

Haibo Mou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.